Table 3.
Other associated mammographic findings | Asymmetries | |||||||
Asymmetry | Focal | Global | Developing | |||||
Benign | Malignant | Benign | Malignant | Benign | Malignant | Benign | Malignant | |
Distortion | 0 | 2 | 5 | *34 | 1 | 6 | 0 | 0 |
0% | −2.20% | −14.70% | −37.40% | −2.90% | −6.60% | 0% | 0% | |
Suspicious calcifications | 0 | 1 | 0 | *11 | 0 | 5 | 0 | 0 |
0% | −1.10% | 0% | −12.10% | 0% | −5.50% | 0% | 0% | |
Skin/nipple changes | 2 | 1 | 5 | *31 | 3 | 16 | 0 | 0 |
−5.90% | −1.10% | −14.70% | −34.10% | −8.80% | −17.60% | 0% | 0% | |
Axillary LN | 1 | 1 | 0 | 13 | 1 | 4 | 0 | 0 |
−2.90% | −1.10% | 0% | −14.30% | −2.90% | −4.40% | 0% | 0% | |
No other findings | 1 | 2 | *14 | 7 | 4 | 0 | 0 | 1 |
−2.90% | −2.20% | −41.20% | −7.70% | −11.80% | 0% | 0% | −1.10% |
LN, lymph node.
34.4%of patients who had focal asymmetry and distortion had a malignancy.
12.1%of patients who had focal asymmetry and suspicious calcifications had a malignancy.
34.1%of patients who had focal asymmetry and skin/nipple changes had a malignancy.
41.2%of patients who had focal asymmetry with no other mammographic findings were considered benign cases.
p≤0.001